No significant mutations were observed in SUFU. Multi-layered mutations in Hh pathway may change the activation level of the Hh signals, which may explain the wide phenotypic variability of Gorlin syndrome. The gene discussed is SUFU; the disease is nevoid basal cell carcinoma syndrome.